Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

AZTA

Azenta (AZTA)

Azenta Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AZTA
DateHeureSourceTitreSymboleSociété
24/04/202522h15PR Newswire (US)Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
09/04/202522h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZTAAzenta Inc
24/03/202521h05PR Newswire (US)Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) ReportNASDAQ:AZTAAzenta Inc
10/03/202522h05PR Newswire (US)Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare ForumNASDAQ:AZTAAzenta Inc
13/02/202522h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AZTAAzenta Inc
10/02/202523h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZTAAzenta Inc
05/02/202513h00PR Newswire (US)Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024NASDAQ:AZTAAzenta Inc
04/02/202522h10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AZTAAzenta Inc
30/01/202522h05PR Newswire (US)Azenta Announces the Election of Dipal Doshi to its Board of DirectorsNASDAQ:AZTAAzenta Inc
27/01/202522h05PR Newswire (US)Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
23/01/202522h05PR Newswire (US)UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research ExcellenceNASDAQ:AZTAAzenta Inc
17/12/202423h30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AZTAAzenta Inc
17/12/202423h29Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AZTAAzenta Inc
17/12/202423h28Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AZTAAzenta Inc
06/12/202422h32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AZTAAzenta Inc
19/11/202423h56PR Newswire (US)Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600NASDAQ:AZTAAzenta Inc
14/11/202414h00PR Newswire (US)Azenta to Participate in Stephens Annual Investment ConferenceNASDAQ:AZTAAzenta Inc
12/11/202422h05PR Newswire (US)Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFONASDAQ:AZTAAzenta Inc
04/11/202422h05PR Newswire (US)Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
04/11/202414h41Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AZTAAzenta Inc
04/11/202414h00PR Newswire (US)Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive ValueNASDAQ:AZTAAzenta Inc
30/10/202421h05PR Newswire (US)Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing TestNASDAQ:AZTAAzenta Inc
04/09/202414h00PR Newswire (US)AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEONASDAQ:AZTAAzenta Inc
12/08/202422h05PR Newswire (US)GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week EventNASDAQ:AZTAAzenta Inc
06/08/202422h05PR Newswire (US)Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024NASDAQ:AZTAAzenta Inc
05/08/202422h05PR Newswire (US)Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceNASDAQ:AZTAAzenta Inc
01/08/202422h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AZTAAzenta Inc
24/07/202422h05PR Newswire (US)Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and WebcastNASDAQ:AZTAAzenta Inc
22/07/202422h05PR Newswire (US)FinnGen Selects Azenta to Propel Personalized Medicine for Population Health StudyNASDAQ:AZTAAzenta Inc
04/06/202422h05PR Newswire (US)Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical ResearchNASDAQ:AZTAAzenta Inc
 Showing the most relevant articles for your search:NASDAQ:AZTA

Dernières Valeurs Consultées

Delayed Upgrade Clock